Current Report Filed: 2026-01-16

Key Insights

  • Value Line appointed Dr. Alexander J. Swistel to its Board of Directors and Audit Committee, bringing medical and academic expertise to the company.
  • The appointment comes after the passing of previous director Mr. Alfred R. Fiore, indicating a transition in the company's board composition.
  • Dr. Swistel will receive the standard director's fee of $40,000 per year, in line with the company's existing compensation structure for board members.

Filings on this page are at least 90 days old. In the app, any new Value Line Inc. filing is analysed the moment you open it.

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.